Skip to content
Screener

Celcuity CELC Total Equity

Total Equity at other companies

Eli Lilly logo
Eli LillyLLY
$33.88B+85.4%
Gilead Sciences logo
Gilead SciencesGILD
$11.83B-39.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$2.28B-38.2%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$890.01M+33.7%
Immunome logo
ImmunomeIMNM
$588.69M+91.7%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$415.56M+89.1%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Celcuity’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies (Note 6)--
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,500,000 shares authorized as of March 31, 2026, and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026, and December 31, 2025
Common stock, $0.001 par value; 95,000,000 shares authorized as of March 31, 2026, and December 31, 2025; 48,347,390 and 48,244,960 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively4848
Additional paid-in capital555,215549,404
Accumulated deficit(501,738)(448,897)
Total stockholders’ equity53,525100,555
Total liabilities and stockholders’ equity$410,164$466,558

Item 1. Financial Statements (unaudited) ITEM

FAQ

What is Celcuity's total equity?
Celcuity (CELC) reported total equity of $53.53M in Q1 2026.
How has Celcuity's total equity changed year-over-year?
Celcuity's total equity decreased by 38.2% year-over-year, from $86.67M to $53.53M.
What is the long-term trend for Celcuity's total equity?
Over 5 years (2020 to 2025), Celcuity's total equity has grown at a 53.8% compound annual growth rate (CAGR), from $11.7M to $100.56M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Celcuity's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude